Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficacy and safety of innate and adaptive immunotherapy combined with standard of care in high-grade gliomas: a systematic review and meta-analysis. | Front Immunol | 2023 | 37483593 | PubTator, text mining | PubMed |
| Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects. | Front Oncol | 2023 | 37483515 | PubTator, text mining | PubMed |
| Targeting glioblastoma multiforme using a novel fusion protein comprising interleukin-13 and staphylococcal enterotoxin B in vitro. | Toxicol In Vitro | 2023 | 37482138 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells. | J Transl Med | 2023 | 37481592 | PubTator, text mining | PubMed |
| NOTCH4 potentiates the IL-13 induced genetic program in M2 alternative macrophages through the AP1 and IRF4-JMJD3 axis. | Int Immunol | 2023 | 37478314 | PubTator, text mining | PubMed |
| A novel role of prognostic nutritional index in predicting the effectiveness of infliximab in Crohn's disease. | Ann Med | 2023 | 37477647 | PubTator, text mining | PubMed |
| Basophils in pruritic skin diseases. | Front Immunol | 2023 | 37465674 | PubTator, text mining | PubMed |
| Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer. | Front Immunol | 2023 | 37457699 | PubTator, text mining | PubMed |
| Integrated multiomic analysis and high-throughput screening reveal potential gene targets and synergetic drug combinations for osteosarcoma therapy. | MedComm (2020) | 2023 | 37457661 | PubTator, text mining | PubMed |
| Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential. | Explor Target Antitumor Ther | 2023 | 37455828 | PubTator, text mining | PubMed |
| Immunotherapeutic Approaches for the Treatment of Glioblastoma Multiforme: Mechanism and Clinical Applications. | Int J Mol Sci | 2023 | 37445721 | PubTator, text mining | PubMed |
| Bioinformatic Identification of Potential RNA Alterations on the Atrial Fibrillation Remodeling from Human Pulmonary Veins. | Int J Mol Sci | 2023 | 37445678 | PubTator, text mining | PubMed |
| Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy. | Cancers (Basel) | 2023 | 37444586 | PubTator, text mining | PubMed |
| Immunotherapy for Recurrent Glioma-From Bench to Bedside. | Cancers (Basel) | 2023 | 37444531 | PubTator, text mining | PubMed |
| B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma. | Cancers (Basel) | 2023 | 37444389 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T Cells in Glioblastoma-Current Concepts and Promising Future. | Cells | 2023 | 37443804 | PubTator, text mining | PubMed |
| Bi-Specific Killer Cell Engager Enhances NK Cell Activity against Interleukin-13 Receptor Alpha-2 Positive Gliomas. | Cells | 2023 | 37443750 | PubTator, text mining | PubMed |
| Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy. | Front Med (Lausanne) | 2023 | 37441689 | PubTator, text mining | PubMed |
| Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis. | Gut Microbes | 2023 | 37431863 | PubTator, text mining | PubMed |
| A robust immune-related gene pairs signature for predicting the overall survival of esophageal cancer. | BMC Genomics | 2023 | 37430202 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=17